Collaborative Drug Discovery, Inc.

Collaborative Drug Discovery, Inc.

Collaborative Drug Discovery, Inc.

Overview
Date Founded

2004

Headquarters

1633 Bayshore Highway,Suite 342,Burlingame, CA 94010-1515

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

IT Consulting & Services
Holding Companies
Computer Software

Company Description

Collaborative Drug Discovery, Inc. provides drug discovery research informatics. It offers CDD Vault which is a hosted biological and chemical database that securely manages private and external data. The firm also provides modern data management and data visualization services. The company was founded by Barry A. Bunin in 2004 and is headquartered in Burlingame, CA.

Contact Data
Trying to get in touch with decision makers at Collaborative Drug Discovery, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer & Director

Chief Scientific Officer

Head of Sales, Europe

Head-Sales & Sales Operations

Chief Technology & Security Officer

Director, Product Management

Customer Success Manager

Research Scientist

Head of Operations

Collaborator

Board of Directors

Former Chief Executive Officer at Niehaus Ryan Wong, Inc.

Co-Founder at InnoCentive, Inc.

Chief Executive Officer & Director at Collaborative Drug Discovery, Inc.

Former Professional at Symyx Technologies, Inc.

Paths to Collaborative Drug Discovery, Inc.
Potential Connections via
Relationship Science
You
Collaborative Drug Discovery, Inc.
Non-Profit Donations & Grants Received
Investors
Details Hidden

Omidyar Network invests companies located globally. The firm targets companies in sectors such as consumer internet & mobile, education, financial inclusion, governance & citizen engagement and property rights. They provide financing for early stage capital requirements with an initial investments greater than $1 million.

Details Hidden

Founders Fund Management focuses on seed and early-stage investments in high-growth companies within the technology sector. The firm is particularly interested in emerging consumer Internet companies. Investments typically range from $500,000 to $5 million.

Details Hidden

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. Its products include Forteo, Adrica, BAQSIMI, Basaglar and Glucagn. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Collaborative Drug Discovery, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Collaborative Drug Discovery, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Collaborative Drug Discovery, Inc..